Track the TELIX QSAM INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.3bn. The latest transaction was disclosed on 2 May 2024 (Disposition). Among the most active insiders: Nelson Christopher M.. The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
6 ops.
Sell Volume
Fundamental score
Ranked 23,063 of 29,051 companies
31.1
score / 100
Value
31
Quality
31
FCF yld-1.8%
Earn yld-0.2%
EV/EBITDA·
ROE-1.9%
Gross mgn53%
Net mgn-0.9%
Debt/EBITDA13.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
TELIX QSAM INC. is a company listed on XNAS, focused on developing targeted radiotherapy solutions for cancer treatment. It emphasizes innovation in the field of radiopharmaceutical therapies.